{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:05:33Z","timestamp":1789495533669,"version":"build-2803163510"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antiretroviral therapy (ART) adherence is a key determinant of viral load suppression among people living with HIV (PLHIV). In Ethiopia, evidence on the magnitude of ART adherence and its effect on virological outcomes remains fragmented. This systematic review and meta-analysis aimed to estimate the pooled prevalence of ART adherence and viral load suppression, and to measure the association between adherence and viral suppression among PLHIV in Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This systematic review and meta-analysis used the PRISMA checklist for systematic reviews and meta-analyses. The review protocol has been registered onPROSPERO:(CRD420251125899). PubMed, ScienceDirect, Scopus, Epistemonikos, and Google Scholar were searched. The quality of included articles has been evaluated with a Newcastle\u2013Ottawa Scale (NOS), adapted for observational studies. A random-effects model using restricted maximum likelihood (REML) with Knapp\u2013Hartung adjustment was used to estimate pooled prevalence and odds ratio. Heterogeneity was assessed using I\n                      <jats:sup>2<\/jats:sup>\n                      , \u03c4\n                      <jats:sup>2<\/jats:sup>\n                      , and Cochran\u2019s Q test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 39 studies were included in the final analysis. The pooled prevalence of good ART adherence was 79.4% (95% CI: 74.8%\u201383.4%), while the pooled viral load suppression rate was 77.5% (95% CI: 72.5%\u201381.8%). The pooled odds ratio showed that good ART adherence was strongly associated with viral load suppression (OR = 6.30, 95% CI: 4.84\u20138.19). Substantial heterogeneity was observed across studies for both adherence and viral suppression outcomes (I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u200990%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ART adherence and viral load suppression among PLHIV in Ethiopia are relatively high but remain below global targets. Good adherence was significantly associated with virologic suppression, highlighting adherence as a critical modifiable factor for achieving optimal treatment outcomes. Strengthening adherence support interventions is essential to improve virological success and advance progress toward HIV epidemic control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0358352","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:39:32Z","timestamp":1789493972000},"page":"e0358352","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of antiretroviral therapy adherence on viral load suppression rate among people living with HIV in Ethiopia: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-6368","authenticated-orcid":true,"given":"Desalegn Dawit","family":"Assele","sequence":"first","affiliation":[{"name":"College of Medicine and Health Sciences, Hawassa University","place":["Hawassa, Ethiopia"],"department":["Department of Public Health"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5186-0253","authenticated-orcid":true,"given":"Yitayew Ewnetu","family":"Mohammed","sequence":"additional","affiliation":[{"name":"College of Medicine and Health Sciences, Hawassa University","place":["Hawassa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abera Gezume","family":"Ganta","sequence":"additional","affiliation":[{"name":"College of Health Sciences, Jinka University","place":["Jinka, Ethiopia"],"department":["Department of Public Health"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadele Dana","family":"Darebo","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University","place":["Wolaita Sodo, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-8923","authenticated-orcid":true,"given":"Sileshi Demelash","family":"Sasie","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"pone.0358352.ref001","unstructured":"UNAIDS. Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic. 2025. [cited 2026 May 7]. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2025\/UNAIDS_FactSheet"},{"key":"pone.0358352.ref002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874613601610010034","article-title":"HIV Infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities","volume":"10","author":"ABM Kharsany","year":"2016","journal-title":"Open AIDS J"},{"issue":"12","key":"pone.0358352.ref003","article-title":"Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017","volume":"6","year":"2019","journal-title":"Lancet HIV"},{"issue":"4","key":"pone.0358352.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321024","article-title":"The burden of HIV\/AIDS in Ethiopia: Unveiling 30 years of trends in incidence, mortality, and disability-insights from the Global Burden of Disease study (1990-2021)","volume":"20","author":"TA Kitaw","year":"2025","journal-title":"PLoS One"},{"key":"pone.0358352.ref005","unstructured":"WHO. World Health Organization. Guideline on When To Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. 2015."},{"issue":"5","key":"pone.0358352.ref006","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population","volume":"11","author":"G Wandeler","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0358352.ref007","unstructured":"UNAIDS. Fast-Track - Ending the AIDS epidemic by 2030. 2014 [cited 2026 May 6]. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2014\/JC2686_WAD2014report"},{"issue":"1","key":"pone.0358352.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313481","article-title":"Virological outcomes of antiretroviral therapy and its determinants among HIV patients in Ethiopia: implications for achieving the 95-95-95 target","volume":"20","author":"TA Kitaw","year":"2025","journal-title":"PLoS One"},{"issue":"5","key":"pone.0358352.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276411","article-title":"Barriers and facilitators to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: a mixed-methods systematic review and meta-analysis","volume":"18","author":"LD Hlophe","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"pone.0358352.ref010","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1186\/s12889-024-20013-x","article-title":"The viral load monitoring cascade in HIV treatment programmes in sub-Saharan Africa: a systematic review","volume":"24","author":"A Kippen","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0358352.ref011","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28320","article-title":"Review of antiretroviral therapy coverage in 10 highest burden HIV countries in Africa: 2015-2020","volume":"95","author":"AO Babatunde","year":"2023","journal-title":"J Med Virol"},{"issue":"4","key":"pone.0358352.ref012","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae168","article-title":"Virological suppression and its predictors among HIV\/AIDS patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis","volume":"11","author":"D Melak","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"pone.0358352.ref013","article-title":"Barriers and facilitators for interventions to improve ART adherence in Sub-Saharan African countries: a systematic review and meta-analysis","volume":"18","author":"A Buh","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"pone.0358352.ref014","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4102\/jphia.v16i1.691","article-title":"Achieving the fast track 90-90-90 and 95-95-95 targets in sub-Saharan Africa: a rapid review","volume":"16","author":"CT Nxumalo","year":"2025","journal-title":"J Public Health Afr"},{"key":"pone.0358352.ref015","doi-asserted-by":"crossref","first-page":"1609743","DOI":"10.3389\/fpubh.2025.1609743","article-title":"Barriers to ART adherence in sub-Saharan Africa: a scoping review toward achieving UNAIDS 95-95-95 targets","volume":"13","author":"J Magura","year":"2025","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0358352.ref016","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12981-025-00792-y","article-title":"At a crossroads: confronting setbacks and advancing the 95-95-95 HIV targets in sub-Saharan Africa","volume":"22","author":"O Mukuku","year":"2025","journal-title":"AIDS Res Ther"},{"issue":"6","key":"pone.0358352.ref017","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s10461-019-02716-0","article-title":"Alcohol use and antiretroviral therapy non-adherence among adults living with HIV\/AIDS in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"24","author":"J Velloza","year":"2020","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0358352.ref018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000125","article-title":"Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review","volume":"1","author":"T Heestermans","year":"2016","journal-title":"BMJ Glob Health"},{"issue":"5","key":"pone.0358352.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097353","article-title":"Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia","volume":"9","author":"WM Bezabhe","year":"2014","journal-title":"PLoS One"},{"key":"pone.0358352.ref020","doi-asserted-by":"crossref","first-page":"1390901","DOI":"10.3389\/fpubh.2024.1390901","article-title":"Exploring optimal HAART adherence rates in Ethiopian adults: a systematic review and meta-analysis","volume":"12","author":"MY Gobezie","year":"2024","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0358352.ref021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12879-019-4732-6","article-title":"HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study","volume":"20","author":"AA Desta","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0358352.ref022","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12981-022-00429-4","article-title":"Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study","volume":"19","author":"TG Fuge","year":"2022","journal-title":"AIDS Res Ther"},{"issue":"2","key":"pone.0358352.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211326","article-title":"Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues","volume":"14","author":"T Bvochora","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"pone.0358352.ref024","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0000000000002142","article-title":"Antiretroviral adherence level necessary for HIV viral suppression using real-world data","volume":"82","author":"KK Byrd","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0358352.ref025","volume-title":"National Guidelines for Comprehensive HIV Prevention, Care and Treatment","author":"FMoH. Ministry of Health, Ethiopia","year":"2017"},{"key":"pone.0358352.ref026","article-title":"Risk of bias evaluation of cross-sectional studies: adaptation of the Newcastle-Ottawa Scale","author":"MC Carra","year":"2025","journal-title":"J Periodontal Res"},{"issue":"7109","key":"pone.0358352.ref027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"pone.0358352.ref028","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05177-2","article-title":"Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study","volume":"20","author":"CD Agegnehu","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0358352.ref029","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12879-019-3924-4","article-title":"Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study","volume":"19","author":"M Ahmed","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0358352.ref030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/IDR.S341392","article-title":"Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia","volume":"15","author":"GT Atnafu","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"7","key":"pone.0358352.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289450","article-title":"Determinants of virological failure among HIV clients on second-line antiretroviral treatment at Felege-hiwot and University of Gondar comprehensive specialized hospitals in the Amhara Region, Northwest Ethiopia: a case-control study","volume":"19","author":"G Ayenew","year":"2024","journal-title":"PLoS One"},{"issue":"5","key":"pone.0358352.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303243","article-title":"Viral load suppression and its predictor among HIV seropositive people who receive enhanced adherence counseling at public health institutions in Bahir Dar, Northwest Ethiopia. Retrospective follow-up study","volume":"19","author":"MB Belete","year":"2024","journal-title":"PLoS One"},{"key":"pone.0358352.ref033","article-title":"Predictors of virological failure after adherence-enhancement counseling among first-line adults living with HIV\/AIDS in Kombolcha Town, Northeast Ethiopia","author":"G Bisetegn","year":"2021","journal-title":"HIV\/AIDS-Res"},{"key":"pone.0358352.ref034","first-page":"209","article-title":"Virological outcomes among pregnant women receiving antiretroviral treatment in the Amhara Region, North West Ethiopia","volume":"15","author":"D Endalamaw Alamneh","year":"2023","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0358352.ref035","first-page":"749","article-title":"Determinants of virological failure among adult clients on first-line antiretroviral therapy in Amhara regional state, northeast Ethiopia: a case-control study","volume":"12","author":"Z Fentaw","year":"2020","journal-title":"HIV AIDS"},{"issue":"1","key":"pone.0358352.ref036","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13052-021-01030-7","article-title":"Magnitude and associated factors of virological failure among children on ART in Bahir Dar Town public health facilities, Northwest Ethiopia: a facility based cross-sectional study","volume":"47","author":"B Gelaw","year":"2021","journal-title":"Ital J Pediatr"},{"key":"pone.0358352.ref037","first-page":"709","article-title":"Virological suppression and its associated factors of dolutegravir based regimen in a resource-limited setting: an observational retrospective study in Ethiopia","volume":"13","author":"EA Mehari","year":"2021","journal-title":"HIV AIDS (Auckl)"},{"issue":"1","key":"pone.0358352.ref038","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1038\/s41598-024-53569-0","article-title":"Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: retrospective cohort study","volume":"14","author":"NS Muhie","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0358352.ref039","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12981-020-00294-z","article-title":"Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia","volume":"17","author":"J Nega","year":"2020","journal-title":"AIDS Res Ther"},{"key":"pone.0358352.ref040","first-page":"697","article-title":"Determinants of virologic failure among adults on second line antiretroviral therapy in Wollo, Amhara Regional State, Northeast Ethiopia","volume":"12","author":"A Seid","year":"2020","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0358352.ref041","first-page":"1035","article-title":"Determinants of virological failure among HIV-infected children on first-line antiretroviral therapy in West Gojjam Zone, Amhara Region, Ethiopia","volume":"13","author":"A Shumetie","year":"2021","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0358352.ref042","first-page":"877","article-title":"Rate of viral re-suppression and retention to care among PLHIV on second-line antiretroviral therapy at Dessie comprehensive specialized hospital, Northeast Ethiopia: a retrospective cohort study","volume":"13","author":"S Wedajo","year":"2021","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0358352.ref043","doi-asserted-by":"crossref","first-page":"1249957","DOI":"10.3389\/fped.2024.1249957","article-title":"Incidence and predictors of virological failure among children receiving first-line anti-retroviral treatment in public comprehensive specialized hospitals found in Northeast Ethiopia: a retrospective follow-up study","volume":"12","author":"EB Abebe","year":"2024","journal-title":"Front Pediatr"},{"key":"pone.0358352.ref044","article-title":"Viral load suppression after enhanced adherence counseling and its predictors among high viral load HIV seropositive people in North Wollo Zone public hospitals, Northeast Ethiopia, 2019: retrospective cohort study","author":"G Diress","year":"2020","journal-title":"AIDS Res Treat"},{"key":"pone.0358352.ref045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1929436","article-title":"Determinants of virologic failure among adult HIV patients on first-line antiretroviral therapy at Waghimra Zone, Northern Ethiopia: a case-control study","volume":"2020","author":"A Emagnu","year":"2020","journal-title":"Adv Public Health"},{"issue":"1","key":"pone.0358352.ref046","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4314\/ahs.v21i1.34","article-title":"First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia","volume":"21","author":"A Genet","year":"2021","journal-title":"Afr Health Sci"},{"issue":"8","key":"pone.0358352.ref047","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10169","article-title":"Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020\/2021: a cross-sectional study","volume":"8","author":"T Kiros","year":"2022","journal-title":"Heliyon"},{"key":"pone.0358352.ref048","doi-asserted-by":"crossref","first-page":"1496144","DOI":"10.3389\/fmed.2025.1496144","article-title":"Time to viral load re-suppression and its predictors among adult patients on second-line anti-retro viral therapy in northeastern Ethiopia: multi-center prospective follow-up study","volume":"12","author":"AY Melaku","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"pone.0358352.ref049","first-page":"931","article-title":"Determinants of virological failure among patients on first-line antiretroviral therapy in central Oromia, Ethiopia: a case-control study","volume":"12","author":"IJ Abdullahi","year":"2020","journal-title":"HIV AIDS (Auckl)"},{"issue":"11","key":"pone.0358352.ref050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289095","article-title":"Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia Region, Ethiopia: A retrospective follow up study","volume":"18","author":"NM Abera","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"pone.0358352.ref051","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-093797","article-title":"Predictive factors associated with virological failure among adult patients living with HIV on first-line highly active antiretroviral therapy in Southeast Oromia, Ethiopia: a case-control study","volume":"15","author":"LK Gedefa","year":"2025","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0358352.ref052","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1186\/s12889-022-14169-7","article-title":"Predictors of unsuppressed viral load among adults on follow up of antiretroviral therapy at selected public and private health facilities of Adama town: unmached case-control study","volume":"22","author":"F Jaleta","year":"2022","journal-title":"BMC Public Health"},{"key":"pone.0358352.ref053","doi-asserted-by":"crossref","first-page":"1484866","DOI":"10.3389\/fpubh.2025.1484866","article-title":"Prevalence of virological failure and associated factors among adult individuals on highly active antiretroviral treatment (HAART) in public health facilities at Tulu Bolo Town, Southwest Shoa, Ethiopia, 2024","volume":"13","author":"A Lamesa","year":"2025","journal-title":"Front Public Health"},{"key":"pone.0358352.ref054","first-page":"73","article-title":"Virological and immunological antiretroviral treatment failure and predictors among HIV positive adult and adolescent clients in Southeast Ethiopia","volume":"14","author":"A Mamo","year":"2022","journal-title":"HIV AIDS (Auckl)"},{"issue":"10","key":"pone.0358352.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275204","article-title":"Incidence, survival time and associated factors of virological failure among adult HIV\/AIDS patients on first line antiretroviral therapy in St. Paul\u2019s Hospital Millennium Medical College-a retrospective cohort study","volume":"17","author":"DE Andarge","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0358352.ref056","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1186\/s12879-024-10002-1","article-title":"Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia","volume":"24","author":"AA Berhane","year":"2024","journal-title":"BMC Infect Dis"},{"key":"pone.0358352.ref057","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/PHMT.S452150","article-title":"Factors affecting virological failure in children receiving first-line antiretroviral therapy in Ethiopian healthcare facilities: a retrospective analysis","volume":"15","author":"M Desalegn","year":"2024","journal-title":"Pediatric Health Med Ther"},{"key":"pone.0358352.ref058","first-page":"319","article-title":"Incidence and predictors of virological failure among adult HIV\/AIDS patients on second-line anti-retroviral therapy, in selected public hospital of Addis Ababa, Ethiopia: retrospective follow-up study","volume":"14","author":"HF Zakaria","year":"2022","journal-title":"HIV AIDS (Auckl)"},{"issue":"1","key":"pone.0358352.ref059","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12985-025-02828-1","article-title":"A retrospective study on HIV virological recovery patterns and factors associated with HIV viral treatment using highly active antiretroviral therapy (HAART) in public health facilities in tigray, Northern Ethiopia","volume":"22","author":"GT Gebrehiwot","year":"2025","journal-title":"Virol J"},{"key":"pone.0358352.ref060","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2147\/IDR.S251619","article-title":"Increased virological failure and determinants among HIV patients on highly active retroviral therapy in Adigrat General Hospital, Northern Ethiopia, 2019: hospital-based cross-sectional study","volume":"13","author":"H Negash","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"10","key":"pone.0358352.ref061","article-title":"Incidence and predictors of treatment failure among children with HIV on first-line antiretroviral therapy in Wolaita zone, Southern Ethiopia: A multicenter retrospective cohort study","volume":"9","author":"ZB Mena","year":"2023","journal-title":"Heliyon"},{"key":"pone.0358352.ref062","doi-asserted-by":"crossref","first-page":"916454","DOI":"10.3389\/fpubh.2022.916454","article-title":"Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: A case-control study","volume":"10","author":"B Bogale","year":"2022","journal-title":"Front Public Health"},{"key":"pone.0358352.ref063","doi-asserted-by":"crossref","first-page":"1384787","DOI":"10.3389\/fpubh.2024.1384787","article-title":"Time to viral load suppression and its predictors among people living with HIV on antiretroviral therapy in Gebi Resu zone, Afar Region, Ethiopia, 2023","volume":"12","author":"AT Chirnet","year":"2024","journal-title":"Front Public Health"},{"key":"pone.0358352.ref064","first-page":"529","article-title":"Magnitude of viral load suppression and associated factors among clients on antiretroviral therapy in public hospitals of Hawassa City Administration, Ethiopia","volume":"14","author":"AA Anito","year":"2022","journal-title":"HIV AIDS (Auckl)"},{"issue":"30","key":"pone.0358352.ref065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000043255","article-title":"Determinants of virological failure among people living with HIV receiving first-line antiretroviral therapy in Hiwot Fana Comprehensive University Hospital, Eastern Ethiopia","volume":"104","author":"K Nuredin","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"pone.0358352.ref066","first-page":"157","article-title":"Time to viral load suppression and its predictors among adult patients on antiretro viral therapy in Nigist Eleni Mohammed Memorial comprehensive specialized hospital, Hossana, Southern Ethiopia","volume":"15","author":"E Erjino","year":"2023","journal-title":"HIV AIDS (Auckl)"},{"issue":"3","key":"pone.0358352.ref067","first-page":"102","article-title":"Adherence to antiretroviral therapy among HIV-1 patients from sub-Saharan Africa: a systematic review","volume":"26","author":"PRS Almeida","year":"2024","journal-title":"AIDS Rev"},{"issue":"1","key":"pone.0358352.ref068","article-title":"Adherence to antiretroviral therapy for HIV\/AIDS in Latin America and the Caribbean: systematic review and meta-analysis","volume":"21","author":"M Costa J de","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"pone.0358352.ref069","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/PPA.S445164","article-title":"Adherence to Anti-Retroviral Therapy (ART) and its determinants among people living with HIV\/AIDS at Bonga, Kaffa, South-West Ethiopia","volume":"18","author":"A Tekle","year":"2024","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"pone.0358352.ref070","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2540","article-title":"Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysis","volume":"34","author":"IH Mosha","year":"2024","journal-title":"Rev Med Virol"},{"issue":"2","key":"pone.0358352.ref071","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/aam.aam_42_23","article-title":"Predictors of viral suppression among adults living with HIV\/AIDS in Nigeria: a retrospective chart review","volume":"23","author":"IA Ogunyinka","year":"2024","journal-title":"Ann Afr Med"},{"issue":"1","key":"pone.0358352.ref072","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1186\/s12879-024-10072-1","article-title":"Trends in viral load suppression among HIV patients on antiretroviral therapy (ART) at Asante Mampong Municipal Hospital, Ghana: 2019-2023","volume":"24","author":"GA Kyere","year":"2024","journal-title":"BMC Infect Dis"},{"key":"pone.0358352.ref073","doi-asserted-by":"crossref","first-page":"1658229","DOI":"10.3389\/fpubh.2025.1658229","article-title":"HIV response financing challenges in Sub-Saharan Africa: barriers to achieving the 95-95-95 UNAIDS targets","volume":"13","author":"BW Kulohoma","year":"2025","journal-title":"Front Public Health"},{"key":"pone.0358352.ref074","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000002983","article-title":"The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture","volume":"35","author":"K Heath","year":"2021","journal-title":"AIDS"},{"key":"pone.0358352.ref075","unstructured":"WHO. WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls. 2020 [cited 2026 May 6]. Available from: https:\/\/www.who.int\/news-room\/detail\/06-07-2020-who-access-to-hiv-medicines-severely-impacted-by-covid-19-as-aids-response-stalls"},{"key":"pone.0358352.ref076","unstructured":"UNAIDS. Global AIDS Update Seizing the moment Tackling entrenched inequalities to end epidemics. 2020. [cited 2026 May 6]. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2020\/global-aids-report"},{"issue":"9","key":"pone.0358352.ref077","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30288-6","article-title":"Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study","volume":"8","author":"AB Hogan","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"3","key":"pone.0358352.ref078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282652","article-title":"Progress in scale up of HIV viral load testing in select sub-Saharan African countries 2016-2018","volume":"18","author":"PN Fonjungo","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"pone.0358352.ref079","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-025-12301-7","article-title":"Virologic failure and its determinants among HIV patients progress towards the third 95% global target in Ethiopia: a systematic review and meta-analysis","volume":"26","author":"AT Telayneh","year":"2026","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0358352.ref080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054019","article-title":"Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis","volume":"12","author":"SB Gumede","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"pone.0358352.ref081","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/QAI.0b013e3182615ad1","article-title":"Second-line antiretroviral therapy: long-term outcomes in South Africa","volume":"61","author":"RA Murphy","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0358352.ref082","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231162354","article-title":"Factors associated with adherence and viral suppression among patients on second-line antiretroviral therapy in an urban HIV program in Kenya","volume":"11","author":"R Nyaboke","year":"2023","journal-title":"SAGE Open Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:39:49Z","timestamp":1789493989000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358352"}},"subtitle":[],"editor":[{"given":"Ibrahim","family":"Jahun","sequence":"first","affiliation":[{"name":"SKYDA Health Nigeria","place":["NIGERIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":82,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0358352","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}